DR. THOMAS DILLARD GARY M.D. NPI 1093891921

NPI Details

DR. Thomas Dillard Gary, M.D. is a family medicine in Blairsville, GA with 21 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Thomas Dillard Gary, M.D. NPI is 1093891921. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MERCER UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2005

The provider's business location address is:

346 DEEP SOUTH FARM RD STE A
BLAIRSVILLE, GA
ZIP 30512-218
Phone: (706) 745-9417
Fax: (706) 896-0877

The NPI 1093891921 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Annual depression screening, 15 minutes (HCPCS:G0444)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Automated urinalysis test (HCPCS:81003)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Blood test, clotting time (HCPCS:85610)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Removal of impacted ear wax (HCPCS:69210)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99487)
• Pneumococcal vaccine, 13-valent (HCPCS:90670)
• Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99489)
• Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report (HCPCS:G0403)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Hemoglobin a1c level (HCPCS:83036)
• Administration of vaccine (HCPCS:90471)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/31/2006 and was last updated on 9/15/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.